Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TFF Pharmaceuticals (TFFP)
NASDAQ:TFFP
TFF Pharmaceuticals (TFFP) Stock Price & Analysis
421 Followers
TFFP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.32 - $13.50
Previous Close$2
Volume13.52K
Average Volume (3M)40.61K
Market Cap
$6.20M
Enterprise Value-$3.37M
Total Cash (Recent Filing)$9.70M
Total Debt (Recent Filing)$134.96K
Price to Earnings (P/E)―
Beta1.15
Next Earnings
Aug 14, 2024EPS Estimate
-$1.78Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.21
Shares Outstanding3,098,134
10 Day Avg. Volume34,089
30 Day Avg. Volume40,612
Standard Deviation0.22
R-Squared0.12
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.39
Price to Sales (P/S)10.87
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-3.61
Enterprise Value/Gross Profit-6.79
Enterprise Value/Ebitda0.77
Forecast
1Y Price Target
$4.00Price Target Upside101.01% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
TFF Pharmaceuticals News
Bulls Say, Bears Say
Bulls Say
Clinical TrialsThe Phase II trial on TFF TAC for preventing organ rejection in lung transplant patients shows promising results, as all six patients who completed the 12-week treatment opted to continue with the therapy.
Patient SafetyNo patients discontinued the TFF TAC therapy due to adverse events, and kidney function was maintained, highlighting the treatment's safety profile.
Transition SuccessAll eight patients successfully transitioned from oral tacrolimus to TFF TAC without any evidence of acute rejection, demonstrating the treatment's effectiveness.
Bears Say
Cash FlowTFF Pharmaceuticals' limited cash reserves may not provide sufficient runway into 2024, necessitating additional funding sources.
Stock PricePrice target for TFF Pharmaceuticals has been decreased to $13 per share from $25 per share.
ValuationThe terminal rate in the DCF analysis is decreased from 0% to -15% to reflect long-term risk associated with relying on development of a sole clinical asset.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TFFP FAQ
What was TFF Pharmaceuticals’s price range in the past 12 months?
TFF Pharmaceuticals lowest stock price was $0.32 and its highest was $13.50 in the past 12 months.
What is TFF Pharmaceuticals’s market cap?
Currently, no data Available
When is TFF Pharmaceuticals’s upcoming earnings report date?
TFF Pharmaceuticals’s upcoming earnings report date is Aug 14, 2024 which is in 21 days.
How were TFF Pharmaceuticals’s earnings last quarter?
TFF Pharmaceuticals released its earnings results on May 14, 2024. The company reported -$2.4 earnings per share for the quarter, missing the consensus estimate of -$2.26 by -$0.14.
Is TFF Pharmaceuticals overvalued?
According to Wall Street analysts TFF Pharmaceuticals’s price is currently Undervalued.
Does TFF Pharmaceuticals pay dividends?
TFF Pharmaceuticals does not currently pay dividends.
What is TFF Pharmaceuticals’s EPS estimate?
TFF Pharmaceuticals’s EPS estimate is -$1.78.
How many shares outstanding does TFF Pharmaceuticals have?
TFF Pharmaceuticals has 3,098,134 shares outstanding.
What happened to TFF Pharmaceuticals’s price movement after its last earnings report?
TFF Pharmaceuticals reported an EPS of -$2.4 in its last earnings report, missing expectations of -$2.26. Following the earnings report the stock price went up 8.065%.
Which hedge fund is a major shareholder of TFF Pharmaceuticals?
Among the largest hedge funds holding TFF Pharmaceuticals’s share is Carlson Capital LP. It holds TFF Pharmaceuticals’s shares valued at 1M.
---
TFF Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.00 (101.01% Upside)
$4.00 (101.01% Upside)
Blogger Sentiment
Bullish
TFFP Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.9%
Last 30 Days ▲ 4.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.14%
12-Months-Change
Fundamentals
Return on Equity
-182.42%
Trailing 12-Months
Asset Growth
-49.56%
Trailing 12-Months
Company Description
TFF Pharmaceuticals
TFF Pharmaceuticals, Inc. operates as an early-stage biopharmaceutical company. It develops and commercializes drug products based on its Thin film Freezing (TFF) technology platform. The firm also engages in research, development & drug formulation and initial testing of drug products. The company was founded in 2005 and is headquartered in Toronto, Canada.
---
TFFP Earnings Call
Q3 2023
0:00 / 0:00
---
TFFP Stock 12 Month Forecast
Average Price Target
$4.00
▲(101.01% Upside)
Technical Analysis
Best Analysts Covering TFFP
1 Year
1 Year Success Rate
0/10 ratings generated profit
1 Year Average Return
-63.31%
reiterated a buy rating 4 months ago
Copying Jonathan Aschoff's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -63.31% per trade.
---